Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Zhou, Daming; Dejnirattisai, Wanwisa; Supasa, Piyada; Liu, Chang; J. Mentzer, Alexander; M. Ginn, Helen; Zhao, Yuguang; M. E. Duyvesteyn, Helen; Tuekprakhon, Aekkachai; Nutalai, Rungtiwa; Wang, Beibei; C. Paesen, Guido; López‐Camacho, César; Slon-Campos, Jose; Hallis, Bassam; S. Coombes, Naomi; R. Bewley, Kevin; Charlton, Sue; S. Walter, Thomas; Skelly, Donal; Lumley, Sheila; Dold, Christina; H. Levin, Robert; Dong, Tao; J. Pollard, Andrew; C. Knight, Julian; W. Crook, Derrick; Lambe, Teresa; Clutterbuck, Elizabeth; Bibi, Sagida; Flaxman, Amy; Bittaye, Mustapha; Belij‐Rammerstorfer, Sandra; C. Gilbert, Sarah; James, William; W. Carroll, Miles; Klenerman, Paul; Barnes, Eleanor; Dunachie, Susanna; E. Fry, Elizabeth; Mongkolsapaya, Juthathip; Ren, Jingshan; I. Stuart, David; Screaton, Gavin

doi:10.1016/j.cell.2021.02.037

Public

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Published in Cell • Feb 23, 2021

Authors:

Daming Zhou

Wanwisa Dejnirattisai

Piyada Supasa

Abstract

The race to produce vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began when the first sequence was published, and this forms the basis for vaccines currently deployed globally. Independent lineages of SARS-CoV-2 have recently been reported: UK, B.1.1.7; South Africa,...

Subject

Biology

Virology

Spike Protein

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!